Drug interactions
Alemtuzumab + Upadacitinib
Severity: Major
Alemtuzumab and Upadacitinib: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Alemtuzumab depletes lymphocytes for a prolonged period, and adding upadacitinib increases the risk of serious and opportunistic infections.
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to see why Alemtuzumab and Upadacitinib interact, what to do about it, and the sources.
- Mechanism of action
- Clinical management
- Evidence level
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Upadacitinib
- Abrocitinib + Upadacitinib Contraindicated
- Adenovirus types 4 and 7 live + Upadacitinib Contraindicated
Other interactions of Alemtuzumab
- Alemtuzumab + Fingolimod Major
- Alemtuzumab + Ifosfamide Major
- Alemtuzumab + Lomustine Major
Drug class
- Alemtuzumab
- Miscellaneous
- Upadacitinib
- Musculoskeletal
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
